ADIPOQ and endometrial cancer: The SRR for the “highest” vs “lowest” category of adiponectin levels was 0.47 (95% CI: 0.33–0.66, p < 0.001), which indicated a 53% reduction in endometrial cancer risk (Fig 2) [11–21,30].